Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vanderheyden

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|April 26, 2008
Antagonist-radioligand binding to D2L-receptors in intact cellsAnn Packeu, Jean-Paul De Backer, Isabelle Van Liefde, et al.
European Journal of Pharmacology|May 10, 2005
Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cellsMinh Tam Le, Jean-Paul De Backer, László Hunyady, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Comb-shaped polymer-based Dry electrodes for EEG/ECG measurements with high user comfortY H Chen, M Op de Beeck, L Vanderheyden, et al.
Biochemical Pharmacology|April 19, 2002
Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparationsFrederik L P Fierens, Patrick M L Vanderheyden, Chantal Roggeman, et al.
European Journal of Pharmacology|December 31, 2002
In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptorCatherina Caballero-George, Patrick M L Vanderheyden, Pablo N Solis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humansE Deutsch, J L Vanderheyden, P Gerundini, et al.
Fundamental & Clinical Pharmacology|November 18, 2006
Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelatorsPatrick M L Vanderheyden, Heidi Demaegdt, Julie Swales, et al.
Pharmacological Reviews|August 29, 2015
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]Sadashiva S Karnik, Hamiyet Unal, Jacqueline R Kemp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2006
Intraoperative detection of cell injury and cell death with an 800 nm near-infrared fluorescent annexin V derivativeS Ohnishi, J-L Vanderheyden, E Tanaka, et al.
The Biochemical Journal|May 12, 2005
Metal ion modulation of cystinyl aminopeptidaseHilde Laeremans, Heidi Demaegdt, Jean-Paul De Backer, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|April 26, 2008
Antagonist-radioligand binding to D2L-receptors in intact cellsAnn Packeu, Jean-Paul De Backer, Isabelle Van Liefde, et al.
European Journal of Pharmacology|May 10, 2005
Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cellsMinh Tam Le, Jean-Paul De Backer, László Hunyady, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Comb-shaped polymer-based Dry electrodes for EEG/ECG measurements with high user comfortY H Chen, M Op de Beeck, L Vanderheyden, et al.
Biochemical Pharmacology|April 19, 2002
Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparationsFrederik L P Fierens, Patrick M L Vanderheyden, Chantal Roggeman, et al.
European Journal of Pharmacology|December 31, 2002
In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptorCatherina Caballero-George, Patrick M L Vanderheyden, Pablo N Solis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humansE Deutsch, J L Vanderheyden, P Gerundini, et al.
Fundamental & Clinical Pharmacology|November 18, 2006
Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelatorsPatrick M L Vanderheyden, Heidi Demaegdt, Julie Swales, et al.
Pharmacological Reviews|August 29, 2015
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]Sadashiva S Karnik, Hamiyet Unal, Jacqueline R Kemp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2006
Intraoperative detection of cell injury and cell death with an 800 nm near-infrared fluorescent annexin V derivativeS Ohnishi, J-L Vanderheyden, E Tanaka, et al.
The Biochemical Journal|May 12, 2005
Metal ion modulation of cystinyl aminopeptidaseHilde Laeremans, Heidi Demaegdt, Jean-Paul De Backer, et al.
Pageof 5